Cerebain Biotech Corp. was incorporated on December 18, 2007 under the laws of Nevada. The Company is a smaller reporting biomedical company and through its wholly owned subsidiary, Cerebain Operating, Inc., the Company?s business revolves around the discovery of products for the treatment of Alzheimer?s disease utilizing Omentum. The Company plans to produce products that will include both a medical device solution as well as a synthetic drug solution.